Sladek et al., who first discovered the association between SLC30A8 and T2D, suggested that the finding may have dietary implications, including therapeutic approaches with zinc supplementation or pharmacological manipulation of zinc transport [36]. The gene discussed is SLC30A8; the disease is type 2 diabetes mellitus.